Skip to the main content
Open WellbeingWhat the studies actually measured

Joints, muscles and pain

Vitamin B6and Peripheral neuropathy symptoms

Only one source here so far, and it reported mixed results for peripheral neuropathy symptoms.

How sure anyone can be

Very low certainty, level 1 of 4

Any estimate here is very uncertain.

The numbers reported

No number has been put on this yet. One source recorded only which way the numbers went — for now, that is all we have here.

One source, newest first

What we read is the published abstract, not the full paper, so a blank below may still be printed in the paper itself. A fixed rule worked this out from the source’s own fields. Nobody checked this rating by hand.

  • Systematic review, 2008 · 13 studies pooled

    Very low certainty, level 1 of 4

    Vitamin B for treating peripheral neuropathy.

    Cochrane Database Syst Rev. 2008;2008(3):CD004573. doi:10.1002/14651858.CD004573.pub3. PMID:18646107.

    This source later carried a notice: Update of doi: 10.1002/14651858.CD004573.pub2. The number below is exactly as the source gave it.

    Number reported
    Not in the abstract
    Which way it went
    Mixed results
    Likely range
    Not in the abstract
    Source’s own words
    no pooled estimate; results reported narratively across 13 small trials
    Who was studied
    Adult with peripheral neuropathy
    Compared with
    placebo, or a different vitamin B dose, or active comparators
    Amount taken
    Not in the abstract
    For how long
    14 to 56 days
    Disagreement between studies
    Not in the abstract
    Kind of record
    Journal article
    How this rating was reachedstarts at High, 3 steps down: risk of bias, imprecision and inconsistency
    1. Starts at High
    2. Risk of bias brought it down to Moderatethe abstract reports no risk-of-bias or quality appraisal, so study limitations cannot be ruled outNot in the abstract
    3. Imprecision brought it down to Lowthe abstract reports no confidence interval for the estimateNot in the abstract
    4. Inconsistency brought it down to Very lowpooled studies disagree on the direction of effectReported in the abstract
    5. Ends at Very low3 steps down.
    Checked, nothing to step it down for
    indirectness

    Imprecision stops at the first check that applies; others may apply too.

    AI review could not confirm it — an AI agent re-read this finding against the saved source and at least one check failed. The batch record names the check and quotes the sentence that caused the doubt. No person read it.

    Read the abstract on PubMed

What is still missing from these readings

  • No number at all, only which way it went.
  • One gives no likely range, so how precise that number is is unknown.
  • One do not say how many people took part.
  • Amount taken — Not in the abstract.

Something nobody wrote down is never a zero and never a guess.

Still to read for Vitamin B6

Two of the nine things on our list for Vitamin B6 have no reading here yet:

  • High-sensitivity CRP
  • Interleukin-6

Still to read means nobody here has got to it, not that it was tried and did nothing or that no research exists. A pairing on no list is not a gap: we never set out to read it.

Read next

This is a library, not advice. No recommendation, no dose, no diagnosis, no ranking. We never ask about your symptoms, and nothing here is tailored to you.